Table 1 Baseline demographic and clinical characteristics of the patients
Variable | Total (n = 70) | Successful group (n = 57) | Failed group (n = 13) | p Value |
|---|---|---|---|---|
Age, mean (SD), yr | 60 ± 9.6 | 59.7 ± 9.4 | 60.1 ± 9.7 | 0.9034 |
Male, n (%) | 48(68.6) | 42(73.7) | 6(46.2) | 0.1099 |
Risk factors, n (%) | ||||
 Hypertension | 54(77.1) | 45 (78.9) | 9 (69.2) | 0.6988 |
 Diabetes mellitus | 30(42.9) | 26(45.6) | 4(30.8) | 0.3291 |
 Coronary heart disease | 9(12.9) | 7(12.3) | 2(15.4) | 0.8749 |
 Smoking history | 39(55.7) | 34(59.6) | 5(38.5) | 0.1652 |
 Alcohol history | 20(35.1) | 16(28.1) | 4(30.8) | 0.8841 |
 Dyslipidemia | 33(57.9) | 29(50.9) | 4(30.8) | 0.1900 |
Qualifying event, n (%) | ||||
 Progressive stroke | 28(40) | 25(43.9) | 3(23.1) | 0.1675 |
 Recurrent stroke/TIA | 42(60) | 32(56.1) | 10(76.9) |  |
Estimated occlusion duration (d), median (IQR) | 12.5(3, 34) | 9(3, 30) | 60(13.5, 93.5) | 0.0003 |
Estimated occlusion duration, n (%) | ||||
 ≤ 3 months | 65(92.9) | 56(98.2) | 9(69.2) | 0.0035 |
 > 3 months | 5(7.1) | 1(1.8) | 4(30.8) |  |
Time from imaging-documented occlusion to intervention(d), median (IQR), | 8.5(3,28) | 5(2,24.5) | 52(9.5,88.5) | 0.0007 |